Duncan MacCannell
- Infectious Diseases top 0.5%
- Viral gastroenteritis research and epidemiology 12
- Clostridium difficile and Clostridium perfringens research 8
- SARS-CoV-2 and COVID-19 Research 5
- SARS-CoV-2 detection and testing 5
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 5
- Endocrinology top 5%
- Enterobacteriaceae and Cronobacter Research 3
- Epidemiology top 5%
- Microscopic Colitis 6
-
- Bacterial Identification and Susceptibility Testing 4
- Co-authors
- Gregory L. ArmstrongMarta GwinnThomas LouieMichél LaverdièreAnnie‐Claude LabbéBenjamin J. SilkAdam MacNeilJohn T. Brooks
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Duncan MacCannell
33 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Infectious Diseases 1.6k
- Molecular Medicine 252
- Critical Care and Intensive Care Medicine 208
- Endocrinology 139
- Epidemiology 922
Countries citing papers authored by Duncan MacCannell
This map shows the geographic impact of Duncan MacCannell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duncan MacCannell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duncan MacCannell more than expected).
Fields of papers citing papers by Duncan MacCannell
This network shows the impact of papers produced by Duncan MacCannell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duncan MacCannell. The network helps show where Duncan MacCannell may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Duncan MacCannell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 15 | |
| 2 | 2021 | 58 | |
| 3 | Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021breakdown → | 2021 | 409 |
| 4 | 2020 | 66 | |
| 5 | 2020 | 33 | |
| 6 | 2017 | 33 | |
| 7 | 2016 | 46 | |
| 8 | 2015 | 7 | |
| 9 | 2015 | 172 | |
| 10 | 2015 | 159 | |
| 11 | 2014 | 150 | |
| 12 | 2014 | 29 | |
| 13 | 2014 | 36 | |
| 14 | 2013 | 40 | |
| 15 | 2013 | 14 | |
| 16 | Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae Producing New Delhi Metallo-Beta-Lactamase — Denver, Colorado, 2012 | 2013 | 4 |
| 17 | 2012 | 43 | |
| 18 | 2012 | 51 | |
| 19 | 2008 | 78 | |
| 20 | 2006 | 133 |
About Duncan MacCannell
Duncan MacCannell is a scholar working on Infectious Diseases, Molecular Medicine and Endocrinology, having authored 33 papers that have together received 2.4k indexed citations. Recurring topics across this work include Viral gastroenteritis research and epidemiology (12 papers), Clostridium difficile and Clostridium perfringens research (8 papers), Microscopic Colitis (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Antibiotic Resistance in Bacteria (5 papers), SARS-CoV-2 detection and testing (5 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Enterobacteriaceae and Cronobacter Research (3 papers). The work is most often cited by research in Infectious Diseases (1.6k citations), Molecular Medicine (252 citations) and Critical Care and Intensive Care Medicine (208 citations). Duncan MacCannell has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Gregory L. Armstrong, Marta Gwinn, Thomas Louie, Michél Laverdière, Annie‐Claude Labbé, Benjamin J. Silk, Adam MacNeil, John T. Brooks, Matthew Biggerstaff and Vivien G. Dugan. Their work appears in journals such as Nature, New England Journal of Medicine and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.